• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖悖论和慢性肾脏病对日本外周动脉疾病患者长期生存的影响。

The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease.

机构信息

Department of Vascular Medicine, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Shibukawa-city, Gunma Prefecture, Japan.

出版信息

J Vasc Surg. 2010 Jul;52(1):110-7. doi: 10.1016/j.jvs.2010.02.008. Epub 2010 May 15.

DOI:10.1016/j.jvs.2010.02.008
PMID:20478682
Abstract

BACKGROUND

This study analyzed risk factors for mortality in peripheral arterial disease (PAD), including body mass index (BMI) and estimated glomerular filtration rate (eGFR). Risk factors for long-term survival are unclear in patients with PAD. The origin of the obesity paradox, a paradoxical decrease in mortality with increasing BMI, is also uncertain in these patients.

METHODS

A prospective cohort study was performed in 652 patients (aged 71.3 +/- 9.4 years old) with PAD.

RESULTS

The 1-, 5-, 10- and 15-year survival rates were 94.5%, 70.4%, 45.2%, and 21.1%, respectively, in patients with intermittent claudication, and 72.7%, 27.2%, 11.6%, and 5.8%, respectively, in those with critical limb ischemia (CLI). In Cox multivariate analysis, a significant association with all-cause mortality was found for CLI (hazard ratio [HR], 1.931; 95% confidence interval [CI], 1.089-3.422; P = .024), diabetes (HR, 2.111; 95% CI, 1.247-3.572; P = .005), BMI (HR, 0.879; 95% CI, 0.804-0.962; P = .005), and eGFR (HR, 0.985; 95% CI, 0.971-0.998l; P = .028). These parameters were also significant risk factors for cardiovascular mortality. Fibrinogen (HR, 1.003; 95% CI, 1.001-1.005; P = .014) and cerebrovascular disease (HR, 1.730; 95% CI, 1.021-2.930; P = .045) were identified as risk factors for all-cause mortality. The adjusted HR for mortality of BMI <21.5 vs >or=21.5 kg/m(2) was 1.772 (95% CI, 1.378-2.279; P < .001). BMI had positive correlations with triglyceride and albumin concentrations and negative correlations with the fibrinogen level and chronic obstructive pulmonary disease (P = .005).

CONCLUSIONS

Low BMI, eGFR, CLI, and diabetes are significant risk factors for mortality in PAD. The obesity paradox was verified and may be partly explained by low BMI mediated by malnutrition and systemic inflammation due to PAD or chronic obstructive pulmonary disease.

摘要

背景

本研究分析了外周动脉疾病(PAD)患者死亡的危险因素,包括体重指数(BMI)和估计肾小球滤过率(eGFR)。PAD 患者的长期生存危险因素尚不清楚。肥胖悖论的起源,即 BMI 增加死亡率反而降低的悖论,在这些患者中也不确定。

方法

对 652 例(年龄 71.3 +/- 9.4 岁)PAD 患者进行前瞻性队列研究。

结果

间歇性跛行患者的 1 年、5 年、10 年和 15 年生存率分别为 94.5%、70.4%、45.2%和 21.1%,而严重肢体缺血(CLI)患者分别为 72.7%、27.2%、11.6%和 5.8%。Cox 多变量分析发现,CLI(危险比[HR],1.931;95%置信区间[CI],1.089-3.422;P =.024)、糖尿病(HR,2.111;95%CI,1.247-3.572;P =.005)、BMI(HR,0.879;95%CI,0.804-0.962;P =.005)和 eGFR(HR,0.985;95%CI,0.971-0.998l;P =.028)与全因死亡率显著相关。这些参数也是心血管死亡率的显著危险因素。纤维蛋白原(HR,1.003;95%CI,1.001-1.005;P =.014)和脑血管疾病(HR,1.730;95%CI,1.021-2.930;P =.045)被确定为全因死亡率的危险因素。BMI <21.5kg/m2 与 BMI≥21.5kg/m2 相比,死亡率的调整 HR 为 1.772(95%CI,1.378-2.279;P <.001)。BMI 与甘油三酯和白蛋白浓度呈正相关,与纤维蛋白原水平和慢性阻塞性肺疾病呈负相关(P =.005)。

结论

低 BMI、eGFR、CLI 和糖尿病是 PAD 患者死亡的重要危险因素。肥胖悖论得到了验证,可能部分可以通过 BMI 来解释,BMI 是由于 PAD 或慢性阻塞性肺疾病导致的营养不良和全身炎症引起的。

相似文献

1
The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease.肥胖悖论和慢性肾脏病对日本外周动脉疾病患者长期生存的影响。
J Vasc Surg. 2010 Jul;52(1):110-7. doi: 10.1016/j.jvs.2010.02.008. Epub 2010 May 15.
2
Predictive value of ankle-brachial index to all-cause mortality and cardiovascular mortality in Chinese patients with chronic kidney disease.踝臂指数对中国慢性肾脏病患者全因死亡率和心血管死亡率的预测价值。
Vasa. 2012 May;41(3):205-13. doi: 10.1024/0301-1526/a000187.
3
The impact of isolated tibial disease on outcomes in the critical limb ischemic population.孤立性胫骨疾病对严重肢体缺血人群治疗结果的影响。
Ann Vasc Surg. 2010 Apr;24(3):349-59. doi: 10.1016/j.avsg.2009.07.034. Epub 2010 Jan 4.
4
Combined effects of smoking and peripheral arterial disease on all-cause and cardiovascular disease mortality in a Chinese male cohort.吸烟和外周动脉疾病对中国男性队列全因和心血管疾病死亡率的综合影响。
J Vasc Surg. 2010 Mar;51(3):673-8. doi: 10.1016/j.jvs.2009.09.024.
5
Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.糖尿病患者和非糖尿病患者下肢血管腔内血运重建后的主要肢体结局
J Endovasc Ther. 2017 Jun;24(3):376-382. doi: 10.1177/1526602817705135. Epub 2017 Apr 25.
6
Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency.血运重建对合并肾功能不全的严重肢体缺血患者的生存获益。
J Vasc Surg. 2012 Sep;56(3):737-45.e1. doi: 10.1016/j.jvs.2012.02.049. Epub 2012 Jun 6.
7
Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.体重指数与接受血管内治疗的肢体严重缺血患者死亡率的复杂关系。
Eur J Vasc Endovasc Surg. 2015 Mar;49(3):297-305. doi: 10.1016/j.ejvs.2014.10.014. Epub 2014 Dec 15.
8
Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.慢性肾脏病对颈动脉介入治疗的围手术期及长期影响。
J Vasc Surg. 2016 Nov;64(5):1295-1302. doi: 10.1016/j.jvs.2016.04.038.
9
Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men.代谢综合征与全因死亡率、心脏事件及心血管事件:对25471名日本中青年男性的随访研究
Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):574-80. doi: 10.1177/1741826710389529. Epub 2011 Feb 14.
10
Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.严重肢体缺血外周血管腔内介入治疗后生存及大截肢的决定因素
J Vasc Surg. 2015 Sep;62(3):655-64.e8. doi: 10.1016/j.jvs.2015.04.391. Epub 2015 Jul 26.

引用本文的文献

1
Eicosapentaenoic Acid Level Predicts Long-Term Survival and Cardiovascular or Limb Event in Peripheral Arterial Disease.二十碳五烯酸水平可预测外周动脉疾病患者的长期生存率及心血管或肢体事件
Ann Vasc Dis. 2024 Jun 25;17(2):135-141. doi: 10.3400/avd.oa.23-00079. Epub 2024 Mar 8.
2
Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes.探索哮喘与慢性共病之间的关联:对临床结局的影响。
Front Med (Lausanne). 2024 Jan 26;11:1305638. doi: 10.3389/fmed.2024.1305638. eCollection 2024.
3
Autologous angiogenic therapy with cultured mesenchymal stromal cells in platelet-rich plasma for critical limb ischemia.
富含血小板血浆中培养的间充质基质细胞自体血管生成疗法治疗严重肢体缺血。
Regen Ther. 2023 Sep 21;24:472-478. doi: 10.1016/j.reth.2023.09.011. eCollection 2023 Dec.
4
Obesity and Peripheral Artery Disease: Current Evidence and Controversies.肥胖与外周动脉疾病:当前证据与争议。
Curr Obes Rep. 2023 Sep;12(3):264-279. doi: 10.1007/s13679-023-00510-7. Epub 2023 May 27.
5
Lumbar Sympathetic Ganglion Block Facilitates Wound Healing in a Rat Ischemic Hindquarter Model.腰交感神经节阻滞促进大鼠缺血后肢模型的伤口愈合。
Plast Reconstr Surg Glob Open. 2023 May 24;11(5):e5010. doi: 10.1097/GOX.0000000000005010. eCollection 2023 May.
6
Lipoprotein(a) is a Promising Residual Risk Factor for Long-Term Clinical Prognosis in Peripheral Arterial Disease.脂蛋白(a)是外周动脉疾病长期临床预后的一个有前景的残余危险因素。
Ann Vasc Dis. 2022 Sep 25;15(3):186-192. doi: 10.3400/avd.oa.22-00046.
7
Mortality risk in patients with underweight or obesity with peripheral artery disease: a meta-analysis including 5,735,578 individuals.患有外周动脉疾病的消瘦或肥胖患者的死亡风险:一项包含 5735578 人的荟萃分析。
Int J Obes (Lond). 2022 Aug;46(8):1425-1434. doi: 10.1038/s41366-022-01143-x. Epub 2022 May 16.
8
Influence of Microalbuminuria on Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease.微量白蛋白尿对周围动脉疾病患者长期生存及心血管或肢体事件的影响
Ann Vasc Dis. 2021 Sep 25;14(3):236-243. doi: 10.3400/avd.oa.21-00045.
9
Association between Body Mass Index and Clinical Outcomes of Peripheral Artery Disease after Endovascular Therapy: Data from K-VIS ELLA Registry.体重指数与血管内治疗后外周动脉疾病临床结局之间的关联:来自K-VIS ELLA注册研究的数据。
Korean Circ J. 2021 Aug;51(8):696-707. doi: 10.4070/kcj.2021.0040.
10
Body composition and mortality in patients undergoing endovascular treatment for peripheral artery disease.外周动脉疾病血管内治疗患者的身体成分与死亡率。
Heart Vessels. 2021 Dec;36(12):1830-1840. doi: 10.1007/s00380-021-01883-2. Epub 2021 Jun 7.